Skip to main content
Equibles
GKOS logo

GKOS · GLAUKOS Corp · Metrics

Track GKOS — free

Use GKOS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GKOS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$171.09 +3.84 (+2.30%) At close · Sep 14
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$10.09B
Shares
58.98M

GKOS metrics

69 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$167.25
Market cap
$10.09B

Price action

20 metrics
Price change (1W)
-5.8%
Price change (30D)
-9.9%
Price change (3M)
+31.9%
Price change (6M)
+72.4%
Price change (YTD)
+48.1%
Price change (1Y)
+91.2%
Trailing year
Price change (5Y)
+219.4%
52-week high
$189.55
52-week low
$74.67
Change from 52-week high
-11.8%
Change from 52-week low
+124.0%
Annualized volatility
52.6%
Annualized volatility (3M)
36.6%
Beta
0.9
RSI (14D)
40.0
Price vs SMA 50
-1.3%
Price vs SMA 200
+27.7%
Avg volume (3M)
802,670
Relative volume
0.7
Average dollar volume
$129.10M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
58.98M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
16.1×
reciprocal yield 6.2%
P / book
14.5
reciprocal yield 6.9%
FCF yield
-0.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
60.7%
Operating margin
-31.6%
Trailing 12 months
Net margin
-30.7%
Gross profit (TTM)
$372.01M
Operating profit (TTM)
−$193.36M
Net income (TTM)
−$188.05M
Trailing 12 months
Diluted EPS (TTM)
$-3.27
FCF margin
-2.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$11.41

Growth

11 metrics
Revenue growth YoY
+49.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$612.84M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.8%
Year over year · more shares
Revenue CAGR (3Y)
+21.5%
Revenue CAGR (5Y)
+17.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-27.6%
Return on assets
-20.4%
Debt / equity
—
Current ratio
5.0
EBITDA (TTM)
−$151.39M
Free cash flow (TTM)
−$12.20M
Quick ratio
4.5
Interest coverage
-39.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$114.48M
Total assets
$920.52M
Total debt
$6.08M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$950,000
Capital expenditures (TTM)
$11.25M
R&D (TTM)
$177.17M
SG&A (TTM)
$386.70M
Stock compensation (TTM)
$80.22M
R&D / revenue
28.9%
Stock compensation / revenue
13.1%

Ownership (13F)

3 metrics
13F filers
367
13F filer change QoQ
+27
Institutional ownership
104.7%

Short interest

3 metrics
Short interest
6.5%
Latest settlement · 6.7 days to cover
Days to cover
6.7d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$22.18M
Insider-sentiment score
12 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1192448 CUSIP 377322102 13F (30d) 15 filings 15 filers Visit website Investor relations